Appendix B
Workshop Agendas
NEW APPROACHES TO BREAST CANCER DETECTION (WORKSHOP #1)
National Academy of Sciences Building
Washington, DC
January 7, 2003
|
9:00 |
Welcome and Introduction Ed Penhoet, Committee Chair |
|
9:10 |
Overview of Current Options in Breast Cancer Detection Laura Esserman, University of California San Francisco |
|
9:40 |
Comparisons of Multiple Modalities: US, PET, MRI, Optical Mitchell Schnall, University of Pennsylvania |
|
10:10 |
Technical Advances in Mammography: Digital Mammography and DEI Etta Pisano, University of North Carolina |
|
10:40 |
Comparison of Four Breast Imaging Techniques Keith Paulsen, Dartmouth |
|
11:10 |
Computer Assisted Diagnosis Maryellen Giger, University of Chicago |
|
11:40 |
DISCUSSION |
|
12:00 |
LUNCH |
|
12:45 |
Introduction to Tumor Markers Jeff Marks, Duke University Medical Center |
|
12:50 |
The Search for Breast Cancer Biomarkers Sara Sukumar, Johns Hopkins Oncology Center |
|
1:20 |
Deciphering the Molecular Signatures of Breast Cancer Lance Liotta, Laboratory of Pathology, National Cancer Institute |
|
1:50 |
Molecular Imaging David Piwnica-Worms, Washington University |
|
2:20 |
DISCUSSION |
|
2:30 |
BREAK |
|
2:45 |
Making Sense of the Mountains of Data: Bioinformatics and Breast Cancer Detection Michael Vannier, National Cancer Institute/University of Iowa |
|
3:15 |
SmartProbe: Spin-off Technology from NASA Richard Hular, BioLuminate, Inc. |
|
3:30 |
TransScan: Post-Script on a 1999 “Medical Breakthrough” John Neugebauer, TransScan Medical, Inc. |
|
3:45 |
Optical Scanning, Almost Approved Phillip C. Thomas, DOBI, Inc. |
|
4:00 |
DISCUSSION |
|
4:15 |
WRAP-UP |
|
4:45 |
ADJOURN |
FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #2)
Keck Center of the National Academies
Washington, DC
February 18, 2003
|
9:00 |
Welcome and Introduction Ed Penhoet, Committee Chair |
|
9:10 |
Marketing Strategies: How Companies Work to Encourage Adoption of New Medical Technologies Laura Shapiro, Siemens Medical Solutions |
|
10:00 |
The Role of Innovative Not-for-Profits in Medical Innovation: Lessons from CaP CURE Howard Soule, CaP CURE |
|
10:50 |
The Role of Breast Cancer Philanthropies in Developing New Approaches to Breast Cancer Detection Susan Braun, Susan G. Komen Foundation |
|
11:40 |
DISCUSSION |
|
3:00 |
ADJOURN |
FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #3)
National Academy of Sciences Building
Washington, DC
March 25, 2003
|
9:30 |
Welcome and Introduction Ed Penhoet, Committee Chair |
|
9:35 |
NCI Programs to Support Development of New Approaches to Breast Cancer Detection Ed Staab, Branch Chief, Diagnostic Imaging, NCI |
|
10:15 |
Regulatory Challenges for In Vitro Diagnostics Joseph Hackett, Special Projects Officer, Office of In Vitro Diagnostics, FDA |
|
10:55 |
Challenges in Assessing the Safety and Efficacy of Cancer Detection Devices David Feigal, Director, Center for Devices and Radiological Health, FDA |
|
11:35 |
DISCUSSION |
|
12:30 |
LUNCH |
|
1:15 |
CMS Perspective on Adoption of New Breast Cancer Detection Technologies Sean Tunis, Acting Chief Medical Officer, CMS |
|
1:55 |
Private Health Payers’ Perspective on Adoption of New Breast Cancer Detection Technologies Alan Rosenberg, Vice President of Medical and Credentialing Policy, WellPoint Health Networks |
|
2:35 |
DISCUSSION |
|
2:50 |
BREAK |
|
3:10 |
Better Information and Decision Tools: The Needs of the Consumer Mary Ropka, University of Virginia Medical School |
|
3:50 |
Decision Support in Breast Cancer Detection Options: Health Systems Perspective Nananda Col, Brigham & Women’s Hospital |
|
4:30 |
DISCUSSION |
|
4:45 |
ADJOURN |
